High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection

Circulation

Volumn 103, Issue 18, 2001, Pages 2283-2288

  Van Lenten, Brian J ^a   Wagner, Alan C ^a   Nayak, Debi P ^a   Hama, Susan ^a   Navab, Mohamad ^a   Fogelman, Alan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arteriosclerosis; Infection; Lipoproteins; Mice; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN A; ARYLDIALKYLPHOSPHATASE; CERULOPLASMIN; CLUSTERIN; HIGH DENSITY LIPOPROTEIN; HYDROLASE; INTERLEUKIN 6; SERUM AMYLOID A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTERY WALL; ARTICLE; CELL CULTURE; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; INFLUENZA VIRUS A; LIPID OXIDATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS PLAQUE; VIRUS STRAIN;

EID: 0035826840     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.18.2283     Document Type: Article

References (33)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Poston RN, Haskard DO, Coucher JR, et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992; 140: 665-673.
3. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095-4103.
4. Britt WJ. Vaccines against human cytomegalovirus: time to test. Trends Microblol. 1996;4:34-38.
5. Jousilahti P, Vartiainen E, Tuomilehto J, et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567-572.
6. Woodhouse PR, Khaw KT, Plummer M, et al. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet. 1994;343:435-439.
7. Meier CR, Jick SS, Derby LE, et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351: 1467-1471.
8. Tillett HE, Smith JW, Gooch CD. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol. 1983;12:344-352.
9. Moazed TC, Campbell LA, Rosenfeld ME, et al. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis. 1999;180:238-241.
10. Van Lenten BJ, Hama SY, de Beer FC, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995;96:2758-2767.
11. Woodhouse PR, Meade TW, Khaw KT. Plasminogen activator inhibitor-1, the acute phase response and vitamin C. Atherosclerosis. 1997;133:71-76.
12. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
13. Bronzert TJ, Brewer HB Jr. New micromethod for measuring cholesterol in plasma lipoprotein fractions. Clin Chem. 1977;23:2089-2098.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
15. Shih DM, Gu L, Xia YR, et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 1998;394:284-287.
16. Auerbach BJ, Kiely JS, Cornicelli JA. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem. 1992;201:375-380.
17. Fogelman AM, Elahi F, Sykes K, et al. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 1988;29:1241-1247.
18. Navab M, Imes SS, Hough GP, et al. Monocyte transmigration induced by modification of LDL in cocultures of human aortic wall cells is due to induction of MCP 1 synthesis and is abolished by HDL. J Clin Invest. 1991;88:2039-2046.
19. Steinbrecher UP, Pritchard PH. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res. 1989;30:305-315.
20. Gan KN, Smolen A, Eckerson HW, et al. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos. 1991;19:100-106.
21. de la Liera Moya M, Alger V, Paul JL, et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux: relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb. 1994;14:1056-1065.
22. Garcia-Sastre A, Durbin RK, Zheng H, et al. The role .of interferon in influenza virus tissue tropism. J Virol. 1998;72:8550-8558.
23. Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res. 1989;30:39-49.
24. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta. 1996;1317:84-94.
25. Navab M, Hama-Levy S, Van Lenten BJ, et al. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest. 1997;99:2005-2019.
26. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995;96:2882-2891.
27. Watson AD, Navab M, Hama SY, et al. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest. 1995;95:774-782.
28. Gelissen IC, Hochgrebe T, Wilson MR, et al. Apolipoprotein J (clusterin) induces cholesterol export from macrophage- foam cells: a potential anti-atherogenic function? Biochem J. 1998;331:231-237.
29. Ehrenwald E, Chisholm GM, Fox PL. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest. 1994;93: 1493-1501.
30. Navab M, Hama SY, Cooke CJ, et al. Normal HDL inhibits three steps in the formation of mildly oxidized LDL: step I. J Lipid Res. 2000;41:1495-1508.
31. Navab M, Hama SY, Ananthraramaiah GM, et al. Normal HDL inhibits three steps in the formation of mildly oxidized LDL: steps 2 and 3. J Lipid Res. 2000;41:1481-1494.
32. Memon RA, Staprans I, Noor M, et al. Infection and inflammation induce LDL oxidation in vivo. Aneriosder Thromb Vase Biol. 2000;20:1536-1542.
33. Hajjar DP. Oxidized lipoproteins and infectious agents: are they in collusion to accelerate atherogenesis? Arterioscler Thromb Vase Biol. 2000; 20:1421-1422.